Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Depression Treatment Therapy Market Research and Forecast, 2018-2023

Published by Orion Market Research Pvt Ltd Product code 425901
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Global Depression Treatment Therapy Market Research and Forecast, 2018-2023
Published: March 6, 2018 Content info:
Description

Global depression treatment market is facing stiff decline. The market is expected to grow at low CAGR of 2.1% for the forecasted period of 2018-2023. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The patent cliff has caused a decline in revenues ranging from few million dollars to billions. The patent expiration and generic drug manufacturers gaining license to manufacturers have forced many branded drug manufacturers to either stop their R&D or to reduce budgets. There are very limited number of new drugs in the pipeline. Decline in revenues is majorly due to fall in the price of once expensive drugs by over 50-90%. Volume shipment is still high and increasing especially in emerging markets.

However, markets for therapies using medical devices such as Vagus nerve stimulation, deep brain stimulation, and smartphones is rising. The devices market is expected to grow at a CAGR of 9.2%. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is also driving the market.

North America and Europe currently are the leading markets. They make up for 70% of the total depression treatment market. The markets are driven by high awareness regarding depression and availability of drugs and therapies. However, the patent cliff has caused a decline in the growth rates of the market. Asia Pacific will have the highest growth rate. Recently the discussion over effects of depression on the economies has been going on. Countries such as India, China and Japan are spending on the research of new treatment methods for treating depression. It is expected that new Asian companies could develop new branded drugs in the near future.

The key players included in the report are: Pfizer, Teva Pharmaceuticals, Johnson and Johnson, Merck & Co., Eli lily and company, Novartis, Sanofi-Aventis, AstraZeneca, and others.

Global depression treatment therapy market by depression type

Global depression treatment therapy market by drugs type

Global depression treatment therapy market by depression treatment device

RESEARCH METHODOLOGY

The market study of depression market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

Financial reports of companies involved in the market

Authentic Public Databases

Whitepapers, research-papers and news blogs

Company websites and their product catalogue.

Supplier Websites such as Alibaba, amazon for pricing analysis.

The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

The Report covers:

Comprehensive research methodology of Global depression treatment therapy Market.

This report also includes detailed and extensive market overview with Analyst insights & key market trends.

Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the Global depression treatment therapy Market.

Insights about market determinants which are stimulating the Global depression treatment therapy Market.

Detailed and extensive market segments with regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents
Product Code: PHM-1302

Table of Contents

1. REPORT SUMMARY

1.1. RESEARCH METHODS AND TOOLS

1.2. MARKET BREAKDOWN

1.2.1. BY SEGMENTS

1.2.2. BY GEOGRAPHY

1.2.3. BY STAKEHOLDERS

2. MARKET OVERVIEW AND INSIGHTS

2.1. DEFINITION

2.2. GAP ANALYSIS

2.3. HISTORICAL ANALYSIS

2.4. CURRENT MARKET TRENDS

2.5. ANALYST INSIGHTS & CURRENT MARKET TRENDS

2.5.1. KEY FINDINGS

2.5.2. RECOMMENDATION

2.5.3. CONCLUSION

2.6. REGULATIONS

2.6.1. TAX LAWS

2.6.1.1. UNITED STATES

2.6.1.2. EUROPEAN UNION

2.6.1.3. CHINA

2.6.1.4. INDIA

2.6.1.5. REST OF THE WORLD

2.6.2. DRUG REGULATIONS

2.6.2.1. UNITED STATES

2.6.2.2. EUROPEAN UNION

2.6.2.3. CHINA

2.6.2.4. INDIA

2.6.2.5. REST OF THE WORLD

2.6.3. TYPE OF DEPRESSION DISORDERS

2.6.3.1. MAJOR DEPRESSION

2.6.3.2. BIPOLAR DEPRESSION

2.6.3.3. SEASONAL AFFECTIVE DISORDER

2.6.3.4. PSYCHOTIC DEPRESSION

2.6.3.5. POSTPARTUM DEPRESSION

2.6.3.6. ATYPICAL DEPRESSION

2.6.3.7. PERSISTENT DEPRESSIVE DISORDER

3. MARKET DETERMINANT

3.1. MOTIVATORS

3.1.1. HIGH OCCURRENCE OF MENTAL HEALTH DISORDERS

3.1.2. INCREASING AWARENESS RELATED TO MENTAL HEALTH DISORDERS

3.1.3. UP SURGING MARKET FOR CHEAPER GENERIC DRUGS

3.1.4. UNHEALTHY LIFESTYLES RESULT IN THE INCREASED SALE OF ANTI-DEPRESSANTS

3.2. RESTRAINTS

3.2.1. HIGH COST OF THERAPIES

3.2.2. SIDE EFFECTS OF DEPRESSION DRUGS

3.2.3. EXPIRING PATENTS AND DRYING PIPELINES

3.3. OPPORTUNITIES

3.3.1. EMERGING MARKETS

3.3.2. INTRODUCTION OF NEW THERAPIES SUCH AS VIRTUAL REALITY

4. MARKET SEGMENTATION

4.1. DEPRESSION TREATMENT THERAPY MARKET BY DEPRESSION TYPE

4.1.1. SEASONAL AFFECTIVE DISORDER (SAD)

4.1.2. MAJOR DEPRESSION

4.1.3. DYSTHYMIA DISORDER

4.1.4. POSTPARTUM DEPRESSION

4.1.5. ATYPICAL DEPRESSION

4.1.6. PSYCHOTIC DEPRESSION

4.1.7. BIPOLAR DISORDER

4.2. DEPRESSION TREATMENT THERAPY MARKET BY DRUGS TYPE

4.2.1. SELECTIVE SEROTONIN REUPTAKE INHIBITORS

4.2.1.1. FLUOXETINE (PROZAC)

4.2.1.2. SERTRALINE (ZOLOFT)

4.2.1.3. ESCITALOPRAM (LEXAPRO)

4.2.1.4. OTHERS SSRIS

4.2.2. ATYPICAL ANTIDEPRESSANTS

4.2.2.1. BUPROPION (WELLBUTRIN)

4.2.2.2. DULOXETINE (CYMBALTA)

4.2.2.3. VENLAFAXINE (EFFEXOR)

4.2.2.4. DESVENLAFEXINE (PRISTIQ)

4.2.2.5. OTHERS ATYPICAL ANTIDEPRESSANTS

4.2.3. TRICYCLIC ANTIDEPRESSANTS

4.3. DEPRESSION TREATMENT THERAPY MARKET BY DEPRESSION TREATMENT DEVICE

4.3.1. TRANSCRANIAL MAGNETIC

4.3.2. DEEP BRAIN STIMULATOR

4.3.3. VIRTUAL REALITY THERAPY

4.3.4. VAGUS NERVE SIMULATOR

4.3.5. SMART PHONE APPLICATIONS

4.3.6. OTHERS DEVICES

5. COMPETITIVE LANDSCAPE

5.1. MARKET SHARE ANALYSIS

5.2. KEY COMPANY ANALYSIS

6. REGIONAL ANALYSIS

6.1. NORTH AMERICA

6.1.1. UNITED STATES

6.1.2. CANADA

6.1.3. REST OF NORTH AMERICA

6.2. EUROPE

6.2.1. UNITED KINGDOM

6.2.2. FRANCE

6.2.3. GERMANY

6.2.4. ITALY

6.2.5. SPAIN

6.2.6. REST OF EUROPE

6.3. ASIA PACIFIC

6.3.1. INDIA

6.3.2. CHINA

6.3.3. JAPAN

6.4. REST OF THE WORLD

7. COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.2. ALLERGAN PLC

7.3. ASTRAZENECA

7.4. BRAIN RESOURCE COMPANY (BRC)

7.5. BRAINSWAY LTD.

7.6. BRISTOL MYERS SQUIBB

7.7. CYBERONICS, INC

7.8. ELECTROMEDICAL PRODUCTS INTERNATIONAL, INC.

7.9. ELI LILLY AND COMPANY

7.10. JOHNSON & JOHNSON

7.11. LANNETT CO INC

7.12. LIFECARE NEURO PRODUCTS LIMITED

7.13. H. LUNDBECK A/S

7.14. MAGVENTURE

7.15. MAYO CLINIC

7.16. MERCK & CO.

7.17. NEUROSIGMA, INC.

7.18. NEURONETICS

7.19. NOVARTIS

7.20. OTSUKA PHARMACEUTICALS

7.21. PFIZER

7.22. ROCHE HOLDING AG

7.23. SANOFI-AVENTIS

7.24. SILVER OAK HEALTH

7.25. SUN PHARMACEUTICAL INDUSTRIES LTD.

7.26. TAKEDA PHARMACEUTICALS

7.27. TEVA PHARMACEUTICALS

7.28. THERAPY CHARLOTTE LLC

7.29. VALEANT PHARMACEUTICALS INTERNATIONAL

7.30. VISTAGEN THERAPEUTICS, INC.

List of Tables

  • TABLE # 1 GLOBAL DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023, ($ MILLION)
  • TABLE # 2 GLOBAL DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TYPE 2017-2023, ($ MILLION)
  • TABLE # 3 GLOBAL SAD MARKET RESEARCH AND ANALYSIS 2017-2023, ($ MILLION)
  • TABLE # 4 GLOBAL MAJOR DEPRESSION MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 5 GLOBAL DYSTHYMIA DISORDER MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 6 GLOBAL POSTPARTUM DEPRESSION MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 7 GLOBAL ATYPICAL DEPRESSION MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 8 GLOBAL PSYCHOTIC DEPRESSION MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 9 GLOBAL BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 10 GLOBAL DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DRUGS TYPE 2017-2023, ($ MILLION)
  • TABLE # 11 GLOBAL DEPRESSION TREATMENT THERAPY DRUGS MARKET RESEARCH AND ANALYSIS BY SSRIS 2017-2023, ($ MILLION)
  • TABLE # 12 GLOBAL FLUOXETINE MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 13 GLOBAL SERTRALINE MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 14 GLOBAL ESCITALOPRAM MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 15 GLOBAL OTHER SSRIS MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 16 GLOBAL DEPRESSION TREATMENT THERAPY DRUGS MARKET RESEARCH AND ANALYSIS BY ATYPICAL ANTIDEPRESSANTS 2017-2023, ($ MILLION)
  • TABLE # 17 GLOBAL BUPROPION MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 18 GLOBAL DULOXETINE MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 19 GLOBAL VENLAFAXINE MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 20 GLOBAL DESVENLAFEXINE MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 21 GLOBAL OTHER ATYPICAL ANTIDEPRESSANTS MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 22 GLOBAL TRICYCLIC ANTIDEPRESSANTS MARKET RESEARCH AND ANALYSIS 2017-2023, ($ MILLION)
  • TABLE # 23 GLOBAL DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TREATMENT DEVICE 2017-2023, ($ MILLION)
  • TABLE # 24 GLOBAL TRANSCRANIAL MAGNETIC MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 25 GLOBAL DEEP BRAIN STIMULATOR MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 26 GLOBAL VIRTUAL REALITY THERAPY MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 27 GLOBAL VAGUS NERVE SIMULATOR MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 28 GLOBAL SMARTPHONE APPLICATIONS MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 29 GLOBAL OTHER DEVICES MARKET RESEARCH AND ANALYSIS 2017-2023, ($MILLION)
  • TABLE # 30 NORTH AMERICA DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TYPE 2017-2023, ($ MILLION)
  • TABLE # 31 NORTH AMERICA DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DRUGS TYPE 2017-2023, ($ MILLION)
  • TABLE # 32 NORTH AMERICA DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TREATMENT DEVICE 2017-2023, ($ MILLION)
  • TABLE # 33 EUROPE DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TYPE 2017-2023, ($ MILLION)
  • TABLE # 34 EUROPE DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DRUGS TYPE 2017-2023, ($ MILLION)
  • TABLE # 35 EUROPE DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TREATMENT DEVICE 2017-2023, ($ MILLION)
  • TABLE # 36 APAC DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TYPE 2017-2023, ($ MILLION)
  • TABLE # 37 APAC DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DRUGS TYPE 2017-2023, ($ MILLION)
  • TABLE # 38 APAC DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TREATMENT DEVICE 2017-2023, ($ MILLION)
  • TABLE # 39 REST OF THE WORLD DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TYPE 2017-2023, ($ MILLION)
  • TABLE # 40 REST OF THE WORLD DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DRUGS TYPE 2017-2023, ($ MILLION)
  • TABLE # 41 REST OF THE WORLD DEPRESSION TREATMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DEPRESSION TREATMENT DEVICE 2017-2023, ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL DEPRESSION TREATMENT THERAPY MARKET SHARE BY DEPRESSION TYPE 2017 VS 2023 (IN %)
  • FIGURE # 2 GLOBAL DEPRESSION TREATMENT THERAPY MARKET SHARE BY DRUGS TYPE 2017 VS 2023 (IN %)
  • FIGURE # 3 GLOBAL DEPRESSION TREATMENT THERAPY MARKET SHARE BY DEPRESSION TREATMENT DEVICE 2017 VS 2023 (IN %)
  • FIGURE # 4 GLOBAL DEPRESSION TREATMENT THERAPY MARKET SHARE BY GEOGRAPHY 2017 VS 2023 (IN %)
  • FIGURE # 5 NORTH AMERICA DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 6 US DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 7 CANADA DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 8 EUROPEAN DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 9 UK DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 10 FRANCE DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 11 GERMANY DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 12 ITALY DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 13 SPAIN DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 14 ROE DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 15 ASIA PACIFIC DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 16 INDIA DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 17 CHINA DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 18 JAPAN DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 19 ROAPAC DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
  • FIGURE # 20 REST OF THE WORLD DEPRESSION TREATMENT THERAPY MARKET SIZE 2017-2023 ($MILLION)
Back to Top